Who makes BCD101 Low Dose Liquid Formulation?

BCD101 Low Dose Liquid Formulation is developed by Bichedam Co., Ltd..

What development phase is BCD101 Low Dose Liquid Formulation in?

BCD101 Low Dose Liquid Formulation is in Phase 1.

Last reviewed 2026-04-19 · How we verify

BCD101 Low Dose Liquid Formulation

Bichedam Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	BCD101 Low Dose Liquid Formulation
Sponsor	Bichedam Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BCD101 Low Dose Liquid Formulation CI brief — competitive landscape report
BCD101 Low Dose Liquid Formulation updates RSS · CI watch RSS
Bichedam Co., Ltd. portfolio CI